As of October 29, 2026, Viking Therapeutics had a market cap of $3.425 billion, which increased by 15.79% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Oct 29, 2026, 4:00 PM ET
Viking Therapeutics Inc. (VKTX)
🌍 United States📈 NASDAQ🏭 Health Care🏢 Biotechnology
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 Viking Therapeutics Market Cap History by Year and Month
Viking Therapeutics Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$3.425B
▼ 13.88%
$3.425B
▼ 9.94%
$3.803B
▼ 0.55%
$3.824B
▲ 3.27%
$3.703B
▼ 18.09%
$4.521B
▲ 18.94%
$3.801B
▲ 5.17%
$3.614B
▼ 3.88%
$3.76B
▼ 3.84%
$3.91B
▲ 19.10%
$3.283B
▼ 17.45%
2025
$3.977B
▼ 11.43%
$3.977B
▼ 4.42%
$4.161B
▼ 3.32%
$4.304B
▲ 45.65%
$2.955B
▼ 2.86%
$3.042B
▼ 16.93%
$3.662B
▲ 23.01%
$2.977B
▼ 1.10%
$3.01B
▼ 7.16%
$3.242B
▲ 19.54%
$2.712B
▼ 16.32%
$3.241B
▼ 11.83%
$3.676B
▼ 18.13%
2024
$4.49B
▲ 141.14%
$4.49B
▼ 23.90%
$5.9B
▼ 27.02%
$8.084B
▲ 14.59%
$7.055B
▼ 0.69%
$7.104B
▲ 12.48%
$6.316B
▲ 8.06%
$5.845B
▼ 14.86%
$6.865B
▼ 21.77%
$8.775B
▼ 2.91%
$9.038B
▲ 15.10%
$7.852B
▲ 223.66%
$2.426B
▲ 30.29%
2023
$1.862B
▲ 158.25%
$1.862B
▲ 52.37%
$1.222B
▲ 24.57%
$0.981B
▼ 11.38%
$1.107B
▼ 19.84%
$1.381B
▼ 4.76%
$1.45B
▼ 10.55%
$1.621B
▼ 26.05%
$2.192B
▲ 3.01%
$2.128B
▲ 61.09%
$1.321B
▲ 52.89%
$0.864B
▲ 25.76%
$0.687B
▼ 4.72%
2022
$0.721B
▲ 100.28%
$0.721B
▲ 131.83%
$0.311B
▼ 0.96%
$0.314B
▲ 50.24%
$0.209B
▼ 14.34%
$0.244B
▲ 5.63%
$0.231B
▲ 4.05%
$0.222B
▲ 29.07%
$0.172B
▼ 6.52%
$0.184B
▼ 20.69%
$0.232B
▼ 11.79%
$0.263B
▼ 9.62%
$0.291B
▼ 19.17%
2021
$0.36B
▼ 12.62%
$0.36B
▼ 13.25%
$0.415B
▼ 8.79%
$0.455B
▼ 7.33%
$0.491B
▼ 5.03%
$0.517B
▲ 7.48%
$0.481B
▲ 2.78%
$0.468B
▲ 14.43%
$0.409B
▼ 18.04%
$0.499B
▲ 2.25%
$0.488B
▼ 2.40%
$0.5B
▼ 6.54%
$0.535B
▲ 29.85%
2020
$0.412B
▼ 29.09%
$0.412B
▼ 12.15%
$0.469B
▲ 14.11%
$0.411B
▼ 3.07%
$0.424B
▼ 12.94%
$0.487B
▼ 4.70%
$0.511B
▼ 2.67%
$0.525B
▲ 1.16%
$0.519B
▲ 24.16%
$0.418B
▲ 22.94%
$0.34B
▼ 20.93%
$0.43B
▼ 5.70%
$0.456B
▼ 21.51%
2019
$0.581B
▲ 5.83%
$0.581B
▲ 9.83%
$0.529B
▲ 13.03%
$0.468B
▼ 5.84%
$0.497B
▼ 1.00%
$0.502B
▼ 9.55%
$0.555B
▼ 7.19%
$0.598B
▲ 7.94%
$0.554B
▼ 1.77%
$0.564B
▼ 21.23%
$0.716B
▲ 18.35%
$0.605B
▲ 3.42%
$0.585B
▲ 6.56%
2018
$0.549B
▲ 289.36%
$0.549B
▼ 31.97%
$0.807B
▼ 16.98%
$0.972B
▼ 20.46%
$1.222B
▲ 54.10%
$0.793B
▲ 28.11%
$0.619B
▲ 9.56%
$0.565B
▲ 11.00%
$0.509B
▲ 142.38%
$0.21B
▼ 5.41%
$0.222B
▼ 30.41%
$0.319B
▲ 67.89%
$0.19B
▲ 34.75%
2017
$0.141B
▲ 487.45%
$0.141B
▲ 62.74%
$86.64M
▲ 27.73%
$67.83M
▲ 25.05%
$54.244M
▲ 88.29%
$28.808M
▼ 0.95%
$29.085M
▼ 2.78%
$29.916M
▲ 5.95%
$28.237M
▼ 15.72%
$33.502M
▼ 4.11%
$34.938M
▼ 4.17%
$36.46M
▲ 20.72%
$30.202M
▲ 25.83%
2016
$24.002M
▼ 27.32%
$24.002M
▲ 10.18%
$21.784M
▲ 0.94%
$21.582M
▼ 22.60%
$27.882M
▲ 7.92%
$25.835M
▼ 4.29%
$26.992M
▲ 11.11%
$24.293M
▼ 8.65%
$26.593M
▼ 4.83%
$27.942M
▲ 103.20%
$13.751M
▼ 21.55%
$17.528M
▼ 12.98%
$20.143M
▼ 39.00%
2015
$33.022M
▼ 59.74%
$33.022M
▲ 6.63%
$30.97M
▼ 43.87%
$55.176M
▼ 3.75%
$57.324M
▼ 4.72%
$60.166M
▲ 0.99%
$59.579M
▼ 14.71%
$69.851M
▼ 7.28%
$75.337M
▼ 6.48%
$80.555M
▼ 1.79%
All market cap values reflect closing prices for the period shown.
📊 Viking Therapeutics Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector: